Lăţea, Luminita Iuliu Haţieganu University of Medicine and Pharmacy - Department of Cardiology, Romania , Negrea, Ştefania L. Iuliu Haţieganu University of Medicine and Pharmacy - Department of Cardiology, Romania , Bolboacă, Sorana D. Iuliu Haţieganu University of Medicine and Pharmacy - Department of Medical Informatics and Biostatistics, Romania

Effects of valsartan and nebivolol on blood pressure, QT dispersion and left ventricular hypertrophy in hypertensive patients

26356

Objectives: The aim of this study was to analyze the antihypertensive effect of Valsartan and Nebivolol and their effects on QT dispersion and left ventricular hypertrophy (LVH) in the treatment of naive hypertensive patients.Methods: A prospective study with a six-month follow-up was conducted on hypertensive patients with LVH and mild/ moderate essential hypertension. The patients were randomly assigned to Valsartan (80 to 160 mg/day) or Nebivolol (5 to 10 mg/day) groups. The study group consisted of 108 patients, 55 in the Valsartan group and 53 in the Nebivolol group.Results: The range of mean systolic blood pressure (SBP) varied from 152±17 (baseline) to 132±17 mmHg (follow-up) in the Valsartan group (p 0.001); from 146±13 to 125±14 mmHg in the Nebivolol group (p 0.001). The decrease in mean diastolic blood pressure (DBP) was 9.5±2.5 mmHg in the Valsartan group and 12.3±5.0 mmHg in the Nebivolol group. A significant reduction in QT and corrected QT (Bazett’s formula) dispersion was observed in both groups, with a slightly higher reduction in the Valsartan group. Echocardiography showed a decrease in the left ventricle mass (LVM) indices (p 0.05) in both groups with a greater reduction in the Valsartan group.Conclusion: Valsartan treatment was as effective as Nebivolol in reducing the 24 hour- SBP after a 6 month treatment. Nebivolol treatment proved to be superior to Valsartan in reducing DBP. Both therapies were effective in reducing the LVH; Valsartan proved to be superior to Nebivolol in reducing the QT interval indexes in relation to blood pressure and LVM reduction.

81

Hypertension , electrocardiography , left ventricular hypertrophy , QT interval , QTc , echocardiography

Dicle Medical Journal

88